Yesterday, Alex Moreno, who is pursuing his industrial PhD at Redoxis in collaboration with Karolinska Institutet, held his half time defense in Stockholm.

He presented his progress in evaluating therapeutic antibodies as potential candidates for treatment of Rheumatoid Arthritis. We are very proud of you Alex and looking forward to having you back with the team in Lund, continuing your exciting project!